Latest News and Press Releases
Want to stay updated on the latest news?
-
STOCKHOLM, Sweden, May 05, 2003 (PRIMEZONE) -- Biolight International AB (publ) (Other OTC:BLGIF): Sales during the first quarter amounted to SEK 457 T (513). The clinical acceptance within the...
-
STOCKHOLM, Sweden, Aug. 29, 2002 (PRIMEZONE) -- Biolight International AB (publ): Second quarter 2002 -- Sales during the first six months amounted to SEK 1,212 T (325). Sales during the...
-
STOCKHOLM, Sweden, June 24, 2002 (PRIMEZONE) -- Biolight has signed its first agreement with the home medical care service in western Goteborg, Sweden, regarding treatment of patients with chronic...
-
STOCKHOLM, Sweden, Feb. 22, 2002 (PRIMEZONE) -- Biolight International AB: Important events during the year: -- A phase III study on decubitus ulcers has been finalised during the year....
-
STOCKHOLM, Sweden, January 30, 2002 (PRIMEZONE) -- The company has reached a distribution agreement regarding Dental Care with C&N Med-Dent CO., Ltd in Taiwan. The company has also signed a...
-
STOCKHOLM, Sweden, Jan. 24, 2002 (PRIMEZONE) -- Biolight: The company has gained FDA approval - 510(k) - for Physiotherapeutic Care. This approval allows the company to market and sell its...